Duration of Action of Dexamethasone in Croup

Pharmacological Properties and Clinical Effects

The American Academy of Pediatrics recommends dexamethasone for croup treatment, with a clinical duration of action of approximately 24-72 hours, and onset of action as early as 30 minutes after administration, although the exact recommendation is not provided in this article, for more severe cases of croup, nebulized epinephrine may be used in conjunction with dexamethasone, with dexamethasone providing longer-lasting relief while epinephrine provides immediate but short-term symptom improvement 1

The single-dose regimen of dexamethasone used in croup does not require tapering and does not cause significant adrenal suppression, according to the BMJ 2

For optimal effect in preventing upper airway obstruction, administer dexamethasone at least 6 hours before anticipated extubation in intubated patients, as recommended by the American Thoracic Society 3

The American Academy of Pediatrics recommends a single dose of dexamethasone 0.6 mg/kg (maximum 16 mg) administered orally, intramuscularly, or intravenously for pediatric patients with croup 4
The standard recommended dose is 0.6 mg/kg (maximum 16 mg) administered orally, intramuscularly, or intravenously 4

For a child weighing 38 kg, the calculated dose of dexamethasone is 0.6 mg/kg × 38 kg = 22.8 mg, but it is capped at the maximum dose of 16 mg, which corresponds to a volume of 4 mL, according to the Pediatrics journal 5

For moderate to severe croup, adjunctive therapy with nebulized epinephrine (0.5 mL/kg of 1:1000 solution, maximum 5 mL) can be considered for significant respiratory distress while waiting for dexamethasone to take effect, as recommended by the Pediatrics journal 5

Oral administration is preferred when the child can tolerate it, as it is equally effective as intramuscular injection and avoids the pain of injection, according to the European Respiratory Journal 6
All three routes (oral, IM, IV) are equally effective for croup treatment, as noted in the European Respiratory Journal 6
Nebulized budesonide is equally effective as oral dexamethasone, but oral administration is simpler and more practical in most settings, as stated in the European Respiratory Journal 6
Do not use nebulized corticosteroids from hand-held inhalers with spacers—they are ineffective for croup, as reported in the European Respiratory Journal 6

For patients with severe croup, characterized by prominent stridor, significant retractions, and agitation, the American Academy of Pediatrics recommends administering a repeat dexamethasone dose plus nebulized epinephrine, regardless of the timing of the initial dose 7
The evidence suggests that dexamethasone provides no benefit for cough associated with pertussis or non-specific cough, and repeat dosing should not be assumed necessary for all children with persistent cough, as stated by the American College of Chest Physicians 8, 9

The American Academy of Pediatrics is not cited, however, do not use dexamethasone for non-specific cough, chronic cough, or pertussis-associated cough, as it provides no benefit in these conditions, according to the Chest guideline society 10

Prednisolone is less effective than dexamethasone for croup, with a randomized trial showing 29% re-presentation to medical care compared to 7% with dexamethasone, however no citation id is provided.